
Ovintiv Inc.
OVVNYSEEnergy● Active
$57.87
+$1.17(+2.06%)
Market Cap$16.3B
P/E Ratio—
52W High$63.46
52W Low$35.47
Ovintiv Inc.(OVV)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · OVV · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $8.74B | $9.15B | $10.88B | $12.46B | $8.66B |
| Cost of Revenue | $6.24B | $4.17B | $4.98B | $5.58B | $4.43B |
| Gross Profit | $2.50B | $4.98B | $5.90B | $6.88B | $4.22B |
| Gross Margin %(computed) | 28.57% | 54.45% | 54.22% | 55.21% | 48.79% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.32B | $0.32B | $0.30B | $0.42B | $0.44B |
| Total Operating Expenses | $0.60B | $3.40B | $3.04B | $3.03B | $2.71B |
| Operating Income | $1.89B | $1.58B | $2.86B | $3.85B | $1.52B |
| Operating Margin %(computed) | 21.65% | 17.25% | 26.32% | 30.91% | 17.54% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.38B | $0.41B | $0.35B | $0.31B | $0.34B |
| Income Before Tax | $0.77B | $1.35B | $2.51B | $3.56B | $1.24B |
| Income Tax Expense | ($0.47B) | $0.23B | $0.42B | ($0.08B) | ($0.18B) |
| Net Income | $1.24B | $1.13B | $2.08B | $3.64B | $1.42B |
| Net Margin %(computed) | 14.22% | 12.29% | 19.16% | 29.18% | 16.35% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $4.83 | $4.25 | $8.02 | $14.34 | $5.44 |
| Wtd Avg Shares | 0.26B | 0.26B | 0.26B | 0.25B | 0.26B |
| EBITDA | $3.35B | $4.05B | $4.69B | $4.98B | $2.77B |
| EBITDA Margin %(computed) | 38.38% | 44.29% | 43.09% | 39.99% | 31.98% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B
深入了解Ovintiv Inc.
关于Ovintiv Inc.(OVV)损益表
Ovintiv Inc.(OVV)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,OVV实现营收$8.74B,毛利润$2.50B(毛利率28.57%),净利润$1.24B(净利率14.22%)。
常见问题
OVV · 4 问Ovintiv Inc.(OVV)2025财年营收为$8.74B,同比down4.5%。
OVV revenueOVV salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08